Cargando…

Dietary Therapy in Secondary Progressive Multiple Sclerosis: A Case Report

A 60-year-old man presented with a history of an acute episode of mono-ocular involvement and several acute spinal cord episodes from 1988 to 1991. Multiple MRIs of the spinal cord and brain and cerebrospinal fluid analysis were consistent with a clinical diagnosis of multiple sclerosis (MS). Follow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nathan, Janak, Khedekar Kale, Dhanashri, Naik, Vidula D, Thakker, Forum, Bailur, Sonal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695296/ https://www.ncbi.nlm.nih.gov/pubmed/31428547 http://dx.doi.org/10.7759/cureus.5341

Ejemplares similares

Substantial Remission in Subacute Sclerosing Panencephalitis by Following the Ketogenic Diet: A Case Report
por: Nathan, Janak, et al.
Publicado: (2019)

A Switch to Polyunsaturated Fatty Acid Based Ketogenic Diet Improves Seizure Control in Patients with Drug-resistant Epilepsy on the Mixed Fat Ketogenic Diet: A Retrospective Open Label Trial
por: Nathan, Janak, et al.
Publicado: (2019)

Multiple challenges for people after transitioning to secondary progressive multiple sclerosis: a qualitative study
por: Bogosian, Angeliki, et al.
Publicado: (2019)

Cognitive and Language Deficits in Multiple Sclerosis: Comparison of Relapsing Remitting and Secondary Progressive Subtypes
por: Ntoskou, Katerina, et al.
Publicado: (2018)

Neurophysiological and clinical biomarkers of secondary progressive multiple sclerosis: A cross-sectional study
por: Tartaglia, Matteo, et al.
Publicado: (2023)

Deciphering Multiple Sclerosis Progression
por: Meca-Lallana, Virginia, et al.
Publicado: (2021)

Efficacy and Safety of Intravenous Cladribine in Patients with Rapidly Evolving or Early Secondary Progressive Multiple Sclerosis
por: Alshamrani, Foziah, et al.
Publicado: (2020)

Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic Review
por: Krajnc, Nik, et al.
Publicado: (2021)

Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis
por: Alcalá Vicente, Carmen, et al.
Publicado: (2022)

Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis
por: Connick, Peter, et al.
Publicado: (2018)

Intrathecal, Not Systemic Inflammation Is Correlated With Multiple Sclerosis Severity, Especially in Progressive Multiple Sclerosis
por: Milstein, Joshua L., et al.
Publicado: (2019)

‘You are just left to get on with it’: qualitative study of patient and carer experiences of the transition to secondary progressive multiple sclerosis
por: Davies, F, et al.
Publicado: (2015)

Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany
por: Solari, Alessandra, et al.
Publicado: (2019)

Vision and Vision-Related Measures in Progressive Multiple Sclerosis
por: Backner, Yael, et al.
Publicado: (2019)

The Role of B Cells in Primary Progressive Multiple Sclerosis
por: Holloman, Jameson P., et al.
Publicado: (2021)

Secondary Prevention in Radiologically Isolated Syndromes and Prodromal Stages of Multiple Sclerosis
por: Amato, Maria Pia, et al.
Publicado: (2022)

Construction of a User-Led Resource for People Transitioning to Secondary Progressive Multiple Sclerosis: Results of an International Nominal Group Study
por: Giovannetti, Ambra Mara, et al.
Publicado: (2020)

The Effect of Disease Modifying Therapies on Disability Progression in Multiple Sclerosis: A Systematic Overview of Meta-Analyses
por: Claflin, Suzi B., et al.
Publicado: (2019)

Sex-Specific Environmental Impacts on Initiation and Progression of Multiple Sclerosis
por: Leffler, Jonatan, et al.
Publicado: (2022)

Consensus on early detection of disease progression in patients with multiple sclerosis
por: Meca-Lallana, José E., et al.
Publicado: (2022)

Editorial: Disease modifying therapies in multiple sclerosis
por: Bonavita, Simona, et al.
Publicado: (2022)

Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis
por: Vohl, Katja, et al.
Publicado: (2019)

Association between improved metabolic risk factors and perceived fatigue during dietary intervention trial in relapsing-remitting multiple sclerosis: A secondary analysis of the WAVES trial
por: Villa, Aneli T., et al.
Publicado: (2023)

Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis
por: Hänninen, Katariina, et al.
Publicado: (2020)

An Atypical Presentation of Progressive Multiple Sclerosis in a Young Black Male
por: Franks, Charles, et al.
Publicado: (2023)

Managing the transition (ManTra): a resource for persons with secondary progressive multiple sclerosis and their health professionals: protocol for a mixed-methods study in Italy
por: Giovannetti, Ambra Mara, et al.
Publicado: (2017)

Multimodal diagnostics in multiple sclerosis: predicting disability and conversion from relapsing-remitting to secondary progressive disease course – protocol for systematic review and meta-analysis
por: Statsenko, Yauhen, et al.
Publicado: (2023)

Mapping the Progressive Treatment-Related Reduction of Active MRI Lesions in Multiple Sclerosis
por: Giorgio, Antonio, et al.
Publicado: (2020)

A Rare Case of Susac's Syndrome Masquerading as Progressive-Relapsing Multiple Sclerosis
por: Darwish, Nedal, et al.
Publicado: (2022)

Influence of Pregnancy in Multiple Sclerosis and Impact of Disease-Modifying Therapies
por: Simone, Isabella Laura, et al.
Publicado: (2021)

Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy
por: Ioannides, Zara A., et al.
Publicado: (2021)

Silent Free Fall at Disease Onset: A Perspective on Therapeutics for Progressive Multiple Sclerosis
por: LoPresti, Patrizia
Publicado: (2018)

Walking Training Enhances Corticospinal Excitability in Progressive Multiple Sclerosis—A Pilot Study
por: Chaves, Arthur R., et al.
Publicado: (2020)

Progression risk stratification with six-minute walk gait speed trajectory in multiple sclerosis
por: Goldman, Myla D., et al.
Publicado: (2023)

Disease activity in primary progressive multiple sclerosis: a systematic review and meta-analysis
por: Blok, Katelijn M., et al.
Publicado: (2023)

Comorbidity in Multiple Sclerosis
por: Magyari, Melinda, et al.
Publicado: (2020)

Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities
por: Margoni, Monica, et al.
Publicado: (2021)

Status of Immunotherapy Acceptance in Chinese Patients With Multiple Sclerosis: Analysis of Multiple Sclerosis Patient Survival Report 2018
por: Zhou, Ran, et al.
Publicado: (2021)

Opportunities and Obstacles Associated With Sequential Immune Reconstitution Therapy for Multiple Sclerosis: A Case Report
por: Garbo, Riccardo, et al.
Publicado: (2021)

Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies
por: Coret, Francisco, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hpn6114ne56f4kqiukd8i3rngo